<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: intern</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'intern'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22intern%22&t=%22intern%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:24:19 +0100</lastBuildDate>
        <item>
            <title>FDA Intern &amp; the Quest for Social Media Guidelines</title>
            <link>http://www.medworm.com/index.php?rid=5097076&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2011%2F08%2Ffda-intern-quest-for-social-media.html</link>
            <description>(Source: Pharma Marketing Blog)</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5097076</comments>
            <pubDate>Wed, 03 Aug 2011 12:02:00 +0100</pubDate>
            <guid isPermaLink="false">5097076</guid>        </item>
        <item>
            <title>PhRMA Intern's Secret identity Revealed!</title>
            <link>http://www.medworm.com/index.php?rid=4152265&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2010%2F11%2Fphrma-interns-secret-identity-revealed.html</link>
            <description>Way back in 2006 I reported what I thought was a violation of PhRMA's DTC Advertising Guidelines to its Office of Accountability. I received a response TWO months later from a certain &quot;Emily M. Johnson.&quot; It was such an unprofessional communication that I complained about it my Pharma Marketing listserv. A reader thought Emily was a &quot;lowly, hassled intern&quot; and she should not be blamed for the poor response. That was enough for me to invent &quot;PhRMA Intern&quot; (see &quot;Adventures of PhRMA Intern!&quot;, a CLASSIC Pharma Marketing Blog post).I imagined that PhRMA Intern was a recent graduate of an Ivy League school and might even be related to Ken Johnson, PhRMA VP of Communications. I thought that I would never learn the TRUE identity of PhRMA Intern. Just now, however, I received this anonymous comment ...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4152265</comments>
            <pubDate>Mon, 08 Nov 2010 15:10:00 +0100</pubDate>
            <guid isPermaLink="false">4152265</guid>        </item>
        <item>
            <title>Ever Google Your Doctor’s Name?</title>
            <link>http://www.medworm.com/index.php?rid=4027157&amp;cid=t_187310_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fever-google-your-doctor%25e2%2580%2599s-name%2F2010.10.03</link>
            <description>Andrew takes you behind the scenes of what health information people are searching for online, and how we know:

Popular Health Search: Your Doctor’s Name from Patient Power® on Vimeo.

			
			*This blog post was originally published at Andrew's Blog* (Source: Better Health)</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4027157</comments>
            <pubDate>Sun, 03 Oct 2010 22:00:01 +0100</pubDate>
            <guid isPermaLink="false">4027157</guid>        </item>
        <item>
            <title>The Mayo Clinic Center For Social Media: What It Represents</title>
            <link>http://www.medworm.com/index.php?rid=3812979&amp;cid=t_187310_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fmayo-clinic-center-for-social-media-%25e2%2580%2593-what-it-represents%2F2010.08.02</link>
            <description>In a move that may represent a new level of social health organization within large institutions, the Mayo Clinic announced that it has launched The Mayo Clinic Center for Social Media. Mayo intends to “accelerate effective application of social media tools throughout Mayo Clinic and to spur broader and deeper engagement in social media by hospitals, medical professionals and patients to improve health globally.”
Look for more information in Mayo’s press release which is diplomatically vague while at the same time lofty and enticing.
So what does this really mean?
The Mayo Clinic recognizes opportunity. The opportunity to formally offer comprehensive social media training to hospitals and medical schools is huge. The Mayo Clinic can and should leverage what they’ve done both to the...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3812979</comments>
            <pubDate>Mon, 02 Aug 2010 14:00:50 +0100</pubDate>
            <guid isPermaLink="false">3812979</guid>        </item>
        <item>
            <title>On Being a Student Therapist: End-of-Semester Reflections</title>
            <link>http://www.medworm.com/index.php?rid=3564029&amp;cid=t_187310_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2010%2F05%2F13%2Fon-being-a-student-therapist-end-of-semester-reflections%2F</link>
            <description>It’s taken me a while to compose this last blog of the semester. How does one wrap up the teachings of 52 client sessions in just a few hundred words? Of course, by no means is this the end of my writings about my work, but the end of my practicum experience has arrived, and with it, thoughts and reflections on my first months as a counselor.
When my supervisor gave me my end-of-the-semester review, she gave me a great compliment, saying that I “seem very comfortable in my skin” and how that is a great asset for a counselor. Of all the words of praise she had given me over the past few months, those meant the most.
Years of my own therapeutic work got me to the place I am today, a place where I can be of most help to others. It has been a long, often difficult, but also rewarding jou...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3564029</comments>
            <pubDate>Thu, 13 May 2010 16:30:12 +0100</pubDate>
            <guid isPermaLink="false">3564029</guid>        </item>
        <item>
            <title>Social Media Intern is Here to Help Pharma Avoid Social Media Faux Pas!</title>
            <link>http://www.medworm.com/index.php?rid=3362579&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2010%2F03%2Fsocial-media-intern-is-here-to-help.html</link>
            <description>Regular readers of Pharma Marketing Blog are familiar with Emily Jameson, aka &quot;FDA Intern&quot; and &quot;PhRMA Intern.&quot; Emily has moved on to accept a position with a leading pharma interactive media agency and is now Social Media Intern! We've watched Emily's career progress from her internship at PhRMA, which hired her fresh out college because she was related to one of PhRMA's VPs, to her stint at FDA where she was instrumental in nudging that organization to call for a public hearing on the regulation of social media.It's only natural, therefore, that Emily has ended up on the agency side of the business where she will be able to directly serve the interests of the pharmaceutical industry, which seems to need all the help it can get these days in terms of avoiding social media faux pas.It is pr...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3362579</comments>
            <pubDate>Sat, 13 Mar 2010 11:11:00 +0100</pubDate>
            <guid isPermaLink="false">3362579</guid>        </item>
        <item>
            <title>PhRMA (Intern) Finds Replacement for Billy Tauzin!</title>
            <link>http://www.medworm.com/index.php?rid=3269873&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2010%2F02%2Fphrma-intern-finds-replacement-for.html</link>
            <description>&quot;Billy Tauzin,&quot; reports the New York Times, &quot;one of the highest paid lobbyists in Washington, is resigning as president of the pharmaceutical industry’s trade group amid internal disputes over its pact with the White House to trade political support for favorable terms in the proposed health care overhaul.&quot;&quot;Christopher A. Viehbacher, a board member of PhRMA and chief executive of Sanofi-Aventis, said in an interview on Wednesday that he still held hope the health care package could pass Congress. 'The most important thing to me in this whole process is that PhRMA was not the bad guy,' he said, adding, 'It has not been without its political cost because it is actually difficult to be bipartisan in all of this.'&quot;PhRMA Intern, however, was quoted as saying &quot;The bipartisan train has left the...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3269873</comments>
            <pubDate>Fri, 12 Feb 2010 19:00:00 +0100</pubDate>
            <guid isPermaLink="false">3269873</guid>        </item>
        <item>
            <title>FDA Intern &amp; the Next Steps Toward Pharma Social Media Salvation!</title>
            <link>http://www.medworm.com/index.php?rid=3019229&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2009%2F11%2Ffda-intern-next-steps-toward-pharma.html</link>
            <description>Now that the big FDA public hearing is over, many people are asking &quot;What's the next steps?&quot; If you are like me, you expect FDA to issue new guidance. My friend John Murray has outlined the usual process FDA goes through when developing guidance here.But some of us are anxious to see if stakeholders can get more involved in the process. For example, does the FDA plan to pull in any outside consultants, or hire additional experts internally, to help craft the guidelines? There are other questions as well, like Will there be an additional comment period after draft guidelines are published?I learned that FDA Intern, strange visitor from an Ivy League school who came to FDA with powers and ability far beyond those of Janet Woodcock or even former FDA commish Andy von Eschenbach, is also on a ...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3019229</comments>
            <pubDate>Sun, 22 Nov 2009 17:32:00 +0100</pubDate>
            <guid isPermaLink="false">3019229</guid>        </item>
        <item>
            <title>Doing well in a Cardiothoracic Surgery Rotation</title>
            <link>http://www.medworm.com/index.php?rid=2570476&amp;cid=t_187310_93_f&amp;fid=36525&amp;url=http%3A%2F%2Fuvamedicine.wordpress.com%2F2009%2F07%2F03%2Fdoing-well-in-a-cardiothoracic-surgery-rotation%2F</link>
            <description>Many times, third-year medical students will have to spend a portion of their required surgical clinical clerkship on Cardiothoracic Surgery. This portion of your surgery clerkship can provide a good informational background for anyone going into medicine, pediatrics or surgery. For the medicine, emergency medicine and anesthesia folks, you get first hand experience with the actions of pressors such as dopamine and dobutamine and other cardio pharmaceuticals in the postop management of these patients. You see the real-time effects of agents like nipride and nitroglycerine because most cardiac surgery patient will have pulmonary artery catheters in place in the immediate post-operative period. For those anticipating entering pediatrics, you will get a chance to see some of the effects of th...</description>
            <author>NJBMD's Blog from Student Doctor Network</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2570476</comments>
            <pubDate>Fri, 03 Jul 2009 22:55:28 +0100</pubDate>
            <guid isPermaLink="false">2570476</guid>        </item>
        <item>
            <title>International Tubal Ligation Reversal: Age 40</title>
            <link>http://www.medworm.com/index.php?rid=2474543&amp;cid=t_187310_177_f&amp;fid=38133&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FTubalReversalBlog%2F%7E3%2F3gXA0IA61Vk%2Finternational-tubal-ligation-reversal-age-40.html</link>
            <description>Susan is an international patient who came to Chapel Hill Tubal Reversal Center from the United Arab Emirates (UAE) to have a tubal ligation reversal and removal of a dermoid ovarian cyst to save her only remaining ovary. (Source: Tubal Reversal Blog)</description>
            <author>Tubal Reversal Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2474543</comments>
            <pubDate>Sun, 14 Jun 2009 14:26:00 +0100</pubDate>
            <guid isPermaLink="false">2474543</guid>        </item>
        <item>
            <title>The 14 Letters. Who at the FDA Knew What and When? FDA Intern Wants to Know!</title>
            <link>http://www.medworm.com/index.php?rid=2341867&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2009%2F04%2F14-letters-who-at-fda-knew-what-and.html</link>
            <description>&quot;My sources inside the agency (but outside of DDMAC) tell me they were caught by surprise by these new DDMAC letters,&quot; says Peter Pitts, author of Drug Wonks, which is widely read by the pharmaceutical industry (see &quot;Sponsored Links: Implications &amp; Applications&quot;).&quot;What does this mean? Does it expose the probability that this important social media issue was not discussed at higher levels? You be the judge – but you can bet they will be now. In fact, I wouldn’t be at all surprised to see this issue discussed at a sitting of the Risk Communications Advisory Committee.&quot;MY sources tell me that FDA Intern is tracking down who discussed these letters at higher levels in the FDA.Yes, it's FDA Intern! Strange visitor from an Ivy League school who came to FDA with powers and ability far bey...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2341867</comments>
            <pubDate>Tue, 07 Apr 2009 18:51:00 +0100</pubDate>
            <guid isPermaLink="false">2341867</guid>        </item>
        <item>
            <title>Peter Rost Gets Serious About Becoming Obama's Choice for the New FDA Commissioner</title>
            <link>http://www.medworm.com/index.php?rid=1963965&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F11%2Fpeter-rost-gets-serious-about-becoming.html</link>
            <description>Today I noticed that Peter Rost -- former Pfizer Marketing VP, turned drug industry whistle blower, author, and blogger -- changed the name of his blog (again!) to PETER ROST FOR FDA COMMISSIONER.It all started when I reported on Pharma Marketing Blog that FDA Intern -- Strange visitor from an Ivy League school who came to FDA with powers and ability far beyond those of Janet Woodcock or even FDA commish Andy von Eschenbach! -- announced her endorsement of Peter Rost as president-elect Obama's nominee choice for the new FDA Commissioner (see &quot;FDA Intern Supports Peter Rost for New FDA Commish!&quot;).Peter himself had re-published on his blog a 2004 press release in which Rahm Emanuel -- Obama's new Chief of Staff -- expressed a glowing opinion of Rost (see &quot;Emanuel Statement: Importation Press...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1963965</comments>
            <pubDate>Sun, 16 Nov 2008 15:33:00 +0100</pubDate>
            <guid isPermaLink="false">1963965</guid>        </item>
        <item>
            <title>FDA Intern Supports Peter Rost for New FDA Commish!</title>
            <link>http://www.medworm.com/index.php?rid=1943362&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F11%2Ffda-intern-supports-peter-rost-for-new.html</link>
            <description>Yes, it's FDA Intern! Strange visitor from an Ivy League school who came to FDA with powers and ability far beyond those of Janet Woodcock or even FDA commish Andy von Eschenbach!FDA Intern! Who can change the course of mighty clinical trials, approve drug ads faster than a speeding bullet, jump through Congressional Subcommittee hoops of fire and ire, and who disguised as Emily Jameson (no relation to Jenna Jameson), mild-mannered intern for a great regulatory agency, fights a never ending battle for fast-track drug approvals, pharmaceutical company user fees, and the FDA way!Like most FDA employees these days, FDA Intern has had problems with her paycheck and also with the direction that the FDA has taken in the dark years under the Bush administration. And like moist Americans, she year...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1943362</comments>
            <pubDate>Fri, 07 Nov 2008 12:25:00 +0100</pubDate>
            <guid isPermaLink="false">1943362</guid>        </item>
        <item>
            <title>PhRMA Intern and the YouTube Guru</title>
            <link>http://www.medworm.com/index.php?rid=1773218&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F09%2Fphrma-intern-and-youtube-guru.html</link>
            <description>BackStoryYes, PhRMA is now on YouTube! Actually, it has launched an integrated media campaign called &quot;Sharing Miracles,&quot; which includes a Web site (set up to resemble a blog, although it does not accept comments from readers), a Sunday-morning cable TV show, and a YouTube channel -- all featuring celebrity spokespeople like Montel Williams (also PhRMA's Partnership for Prescription Assistance program spokesperson) and Greg Louganis (Olympic diving champion of long ago).These and other &quot;low-budget&quot; celebrities are augmented by two lesser, even lower-budget, celebrities: PhRMA president &amp; CEO, Billy Tauzin -- who, representing the &quot;thousands of hard-working men and women who develop new medicines to treat chronic diseases,&quot; provides on-screen introductions and PhRMA Vice President and PR...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1773218</comments>
            <pubDate>Sun, 07 Sep 2008 17:07:00 +0100</pubDate>
            <guid isPermaLink="false">1773218</guid>        </item>
        <item>
            <title>FDA Intern Says Obama's Ad is More Pleasing!</title>
            <link>http://www.medworm.com/index.php?rid=1692163&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F08%2Ffda-intern-says-obamas-ad-is-more.html</link>
            <description>In a previous post, FDA Intern asked readers to take part in a little demonstration of the &quot;Affect Misattribution Procedure&quot; that the FDA proposed to use to test DTC broadcast ads (see &quot;FDA Intern Learns All About the 'Affect Misattribution Procedure'&quot;).But instead of applying this rating methodology to boring DTC ads, it was applied to two political broadcast ads -- one by Sen McCain attacking Sen. Obama and one by Sen. Obama giving an uplifting speech. Of course, when doing the test, FDA Intern did not characterize the test ads in any way.The results, which clearly show that Obama's ad was much more pleasing than McCain's ad, are summarized by FDA Intern below.Click on image to get an enlarged view. (Source: Pharma Marketing Blog)</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1692163</comments>
            <pubDate>Fri, 08 Aug 2008 16:23:00 +0100</pubDate>
            <guid isPermaLink="false">1692163</guid>        </item>
        <item>
            <title>FDA Intern Learns All About the &quot;Affect Misattribution Procedure&quot;</title>
            <link>http://www.medworm.com/index.php?rid=1686241&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F08%2Ffda-intern-learns-all-about-affect.html</link>
            <description>Yes, it's FDA Intern! Strange visitor from an Ivy League school who came to FDA with powers and ability far beyond those of Janet Woodcock or even FDA commish Andy von Eschenbach!FDA Intern! Who can change the course of mighty clinical trials, approve drug ads faster than a speeding bullet, jump through Congressional Subcommittee hoops of fire and ire, and who disguised as Emily Jameson (no relation to Jenna Jameson), mild-mannered intern for a great regulatory agency, fights a never ending battle for fast-track drug approvals, pharmaceutical company user fees, and the FDA way!Today, as every day, FDA spends most of her time reading the Federal Register, where she comes across Docket No. FDA-2007-N-0451, formerly the docket known as 2007N-0321. This docket -- as you may recall from a post ...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1686241</comments>
            <pubDate>Wed, 06 Aug 2008 12:49:00 +0100</pubDate>
            <guid isPermaLink="false">1686241</guid>        </item>
        <item>
            <title>How Risky are Rx Drugs?</title>
            <link>http://www.medworm.com/index.php?rid=1634899&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F07%2Fhow-risky-are-rx-drugs.html</link>
            <description>This article summarizes the discussion I moderated during a panel session at a recent conference. The experts on the panel included: Scott M. Lassman, Partner, FDA Group, WilmerHale LLP; Hugo Stephenson, President, iGUARD.org; and Harry Sweeney, formerly Chairman, Dorland-Sweeney. I've interviewed Dr. Stephenson about iGuard in a Pharma Marketing Talk Podcast (listen to it here: &quot;An Innovative System for Communicating Drug Risks to Patients&quot;) and Harry is a long-time friend and member of my Roundtable of advisors (see here). I met Scott Lassman for the first time at this conference. Prior to his position at WilmerHale LLP, Lassman served as Senior Assistant General Counsel for the Pharmaceutical Research and Manufacturers of America (PhRMA).Side Bar: Scott recalled my name because while wo...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1634899</comments>
            <pubDate>Thu, 17 Jul 2008 11:52:00 +0100</pubDate>
            <guid isPermaLink="false">1634899</guid>        </item>
        <item>
            <title>FDA Intern Gets Her Bonus!</title>
            <link>http://www.medworm.com/index.php?rid=1622142&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F07%2Ffda-intern-gets-her-bonus.html</link>
            <description>According to a CBS News story -- &quot;FDA Execs Reap Lavish Bonuses&quot; -- 28 senior FDA executives took in a combined $1 million in bonuses last year.&quot;They've done such a miserable job these last two years, I think they should leave! Not get bonuses of $40,000 [to] $50,000!&quot; Rep. Bart Stupak, D-Mich., said. &quot;Good grief.&quot;&quot;What we are talking about here is the need to have highly experienced, highly capable technical experts that, without which, the country would suffer,&quot; said FDA Commissioner Andrew von Eschenbach.&quot;These should be referred to not as retention bonuses but blackmail bonuses,&quot; said Tom Schatz, president of Citizens Against Government Waste.All this has not gone unnoticed by Emily, the intern at FDA, as we document in this installment of FDA INTERN!Yes, it's FDA Intern! Strange visit...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1622142</comments>
            <pubDate>Mon, 14 Jul 2008 18:51:00 +0100</pubDate>
            <guid isPermaLink="false">1622142</guid>        </item>
        <item>
            <title>FDA Intern vs. Inebriated Advisory Committee Antagonist</title>
            <link>http://www.medworm.com/index.php?rid=1563900&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F07%2Ffda-intern-vs-inebriated-advisory.html</link>
            <description>Yes, it's FDA Intern! Strange visitor from an Ivy League school who came to FDA with powers and ability far beyond those of Janet Woodcock or even FDA commish Andy von Eschenbach! FDA Intern! Who can change the course of mighty clinical trials, approve drug ads faster than a speeding bullet, jump through Congressional Subcommittee hoops of fire and ire, and who disguised as Emily Jameson (no relation to Jenna Jameson), mild-mannered intern for a great regulatory agency, fights a never ending battle for fast-track drug approvals, pharmaceutical company user fees, and the FDA way!For the &quot;Fans of Emily, PhRMA Intern&quot; who have missed her adventures, I am pleased to announce that she has moved over to take on the job of FDA Intern, which is a switch from the usual career development path from ...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1563900</comments>
            <pubDate>Wed, 02 Jul 2008 18:19:00 +0100</pubDate>
            <guid isPermaLink="false">1563900</guid>        </item>
        <item>
            <title>Peculiar medical research - round 2</title>
            <link>http://www.medworm.com/index.php?rid=1514552&amp;cid=t_187310_105_f&amp;fid=36987&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FIvorKovicMd%2F%7E3%2F310198970%2F</link>
            <description>Conclusions
Many residents say they would lie to a colleague to avoid doing that person a favor. Deceiving colleagues
about clinical issues is less likely, but far more serious. A small percentage say they would falsify a medical
record to protect patient confidentiality, fabricate a laboratory value to avoid ridicule, and lie about performing a neglected aspect of the physical examination to cover up a mistake.
Authors offer some advice to medical educators:

Address the issues of professionalism and collegiality as part of the ethics curriculum that is required for all medical residents.
Be aware that residents, like any group of people, exhibit a wide range of moral behaviors, and, sadly, the possibility that the resident is not telling the truth should be included in the differential d...</description>
            <author>Ivor Kovic, M.D.</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1514552</comments>
            <pubDate>Thu, 12 Jun 2008 06:27:54 +0100</pubDate>
            <guid isPermaLink="false">1514552</guid>        </item>
        <item>
            <title>Montel Williams Seeks Interns for 2008 - I Kid You Not!</title>
            <link>http://www.medworm.com/index.php?rid=1071023&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F12%2Fmontel-williams-seeks-interns-for-2008.html</link>
            <description>Montel Williams, CEO of Letnom Management &amp; Productions, and official spokesperson of PhRMA's Partnership for Prescription Assistance, who recently threatened to &quot;blow up&quot; a 17-year old female intern working for the Savannah Morning News (see back story here), is looking for a &quot;responsible, reliable, and eager&quot; unpaid intern to work during Spring 2008 semester.Here are the details (modified from the real deal posted on EntertainmentCareers.net):Montel Williams Office/Letnom Management and Productions                                                               Intern                           This is a PART TIME Unpaid Internship                           Location:          Definitely NOT Savannah, GE; more like New York City (which needs more bomb threats like a hole in the head)    ...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1071023</comments>
            <pubDate>Wed, 05 Dec 2007 12:42:00 +0100</pubDate>
            <guid isPermaLink="false">1071023</guid>        </item>
        <item>
            <title>PhRMA Intern v. Montel: HS Intern is Saved, But...</title>
            <link>http://www.medworm.com/index.php?rid=1070230&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F12%2Fphrma-intern-v-montel-hs-intern-is.html</link>
            <description>Yes, it's PhRMA Intern! Strange visitor from an Ivy League school who came to PhRMA with powers and ability far beyond those of Ken Johnson.PhRMA Intern! Who can change the course of mighty news stories, bend the truth at will, and who disguised as Emily Jameson (no relation to Jenna Jameson), mild-mannered intern for a great pharmaceutical trade association, fights a never ending battle for believability, justice for pharmaceutical companies, and the PhRMA way!One Day at PhRMA HeadquartersOur story begins at the PhRMA headquarters in Washington, DC where PhRMA Intern -- disguised as mild-mannered real intern Emily Jameson -- is going through her morning routine scanning the newspapers.Emily reports directly to Ken Johnson, SVP at PhRMA and PhRM's chief spokesperson.Usually, Emily sits in ...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1070230</comments>
            <pubDate>Tue, 04 Dec 2007 13:06:00 +0100</pubDate>
            <guid isPermaLink="false">1070230</guid>        </item>
        <item>
            <title>PhRMA Intern Proves &quot;No Strings Attached&quot; to Pharma-Sponsored CME!</title>
            <link>http://www.medworm.com/index.php?rid=696881&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F06%2Fphrma-intern-proves-no-strings-attached.html</link>
            <description>Yes! It's PhRMA Intern!In the last episode of PhRMA Intern, the intrepid Washington, DC visitor from an Ivy League school, disguised as mild-manner Emily Jameson, summer intern at Pharmaceutical Research and Manufacturers of America, helped the industry get a sneak preview of the movie SiCKO (see &quot;PhRMA Intern Makes Movie Mogul an Offer He Can't Refuse!&quot;).In that episode, PhRMA Intern exhibited her dark side and fans wondered if she would continue to employ those powers over all others in her never ending battle for believability, justice for pharmaceutical companies, and the PhRMA way. Or would she develop new and more subtle means of persuasion?The answer may be found in this episode:PhRMA Intern and the No-Strings-Attached CME Proof!Emily, as she has been instructed to do by her boss Ke...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=696881</comments>
            <pubDate>Tue, 26 Jun 2007 16:20:00 +0100</pubDate>
            <guid isPermaLink="false">696881</guid>        </item>
        <item>
            <title>PhRMA Intern Makes Movie Mogul an Offer He Can't Refuse!</title>
            <link>http://www.medworm.com/index.php?rid=675617&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F06%2Fphrma-intern-makes-movie-mogul-offer-he.html</link>
            <description>Yes, it's PhRMA Intern! Strange visitor from an Ivy League school who came to PhRMA with powers and ability far beyond those of Ken Johnson.PhRMA Intern! Who can change the course of mighty news stories, bend the truth at will, and who disguised as Emily Jameson (no relation to Jenna Jameson), mild-mannered intern for a great pharmaceutical trade association, fights a never ending battle for believability, justice for pharmaceutical companies, and the PhRMA way!On a Blog, Far, Far AwayOur story begins last week, when blogger John Mack reported that Michael Moore accused PhRMA of sending a &quot;spy&quot; to the Cannes debut of his documentary SiCKO (see &quot;PhRMA Sent SiCKO Spy to Cannes&quot;).That same day, another blogger -- Ed Silverman at Pharmalot -- received a mysterious phone call from Ken Johnson, ...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=675617</comments>
            <pubDate>Mon, 11 Jun 2007 10:00:00 +0100</pubDate>
            <guid isPermaLink="false">675617</guid>        </item>
        <item>
            <title>Botox Banality Not a Boon for TV Sitcoms</title>
            <link>http://www.medworm.com/index.php?rid=525575&amp;cid=t_187310_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F04%2Fbotox-banality-not-boon-for-tv-sitcoms.html</link>
            <description>Despite extolling the ability to &quot;express yourself&quot; while under the influence of Botox in recent TV &quot;reminder ads&quot; -- which, BTW, go against the self-imposed industry ban on such ads -- TV studios are finding it increasingly difficult to find women actors who can express themselves, according to Wall Street Journal article (&quot;The Backlash to Botox&quot;).Left, Janice Dickinson (Botox Banal) in scenes from her reality show, 'The Janice Dickinson Modeling Agency'; right, Julia Louis-Dreyfus (Botox Free) in 'The New Adventures of Old Christine.'&quot;The rarest commodity in TV these days, say veteran casting directors: stars without Restylane-frozen faces and collagen-inflated lips.&quot;Botox Not Comical&quot;Successful sitcoms,&quot; notes the WSJ, &quot;including 'Old Christine,' typically feature actors and actresses w...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=525575</comments>
            <pubDate>Fri, 06 Apr 2007 12:00:00 +0100</pubDate>
            <guid isPermaLink="false">525575</guid>        </item>
    </channel>
</rss>

